Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Novelion Therapeutics Inc (NQ: NVLN )

0.6800 USD UNCHANGED
Last Price Updated: 4:35 PM EDT, Oct 8, 2019 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Novelion Therapeutics Inc

< Previous 1 2 3 4 5 Next >
The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug
The following is aroundup of top developments in the biotech space over the last 24 hours. None of the NYSE or ... 
Tags ONCS VIE CUR
From Benzinga
Novelion Therapeutics Announces Nasdaq Delisting
From GlobeNewswire News Releases
Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matters
From GlobeNewswire News Releases
The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ... 
Tags SRPT FOLD ANAB
From Benzinga
The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ... 
Tags XGN NKTR BBIO
From Benzinga
Novelion Therapeutics Announces Completion of Aegerion Transaction and Departure of Certain Directors and Officers
From GlobeNewswire News Releases
Novelion Therapeutics Announces US Court Confirmation of Aegerion Bankruptcy Case, Update on Nasdaq Delisting and Date of Annual General Meeting of Shareholders
From GlobeNewswire News Releases
Novelion Therapeutics Provides Update Regarding Delisting from Nasdaq and Aegerion Bankruptcy Case
From GlobeNewswire News Releases
Novelion Therapeutics Announces Issuance of General Cease Trade Order in Canada and Notice of Delisting from Nasdaq
From GlobeNewswire News Releases
The Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly Results
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags PHAS BCLI RUBY
From Benzinga
Novelion Therapeutics Announces Anticipated Late Filing of Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2019
From GlobeNewswire News Releases
Novelion Therapeutics Announces Dismissal of Whitefort Capital Petition
Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare metabolic diseases (“Novelion”), announced that on... 
From GlobeNewswire News Releases
Novelion Therapeutics Receives Delisting Notifications
Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare metabolic diseases, announced that on July 3, 2019,... 
From GlobeNewswire News Releases
Novelion Therapeutics Responds to Whitefort Capital Petition
Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare metabolic diseases (“Novelion”), announced that on... 
From GlobeNewswire News Releases
The 5 Most Expensive Drugs In US: What You Should Know
The upward trajectory of prescription drug prices in the U.S.has drawn the ire of lawmakers. Prices of drugs are staggeringly high ... 
Tags NVS SPPI pharmacy
From Benzinga
Deals of the day-Mergers and acquisitions
The following bids, mergers, acquisitions and disposals were reported by 1130 GMT on Tuesday: 
Tags companyNews
From Reuters: Company News
UPDATE 1-UK Stocks-Factors to watch on May 21
Britain's FTSE 100 index is seen opening 21 points higher at 7,332 on Tuesday, according to financial bookmakers, with futures up 0.38% ahead of the cash market open. 
Tags companyNews
From Reuters: Company News
UK's Amryt Pharma unites lomitapide franchise with Aegerion deal
Britain's Amryt Pharma has agreed to buy Aegerion Pharmaceuticals, a subsidiary of Novelion Therapeutics, in a deal that reunites the franchise for lomitapide, a treatment for patients with a rare... 
Tags companyNews
From Reuters: Company News
Novelion Therapeutics Announces Subsidiary Aegerion Pharmaceuticals to Recapitalize Through Court Supervised Process In Which Amryt Pharma Plc Will Acquire 100% of Reorganized Stock of Aegerion
Novelion Therapeutics Inc. (NASDAQ: NVLN) (Novelion), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases, announced today that its... 
From GlobeNewswire News Releases
Novelion Therapeutics Reports First Quarter 2019 Financial Results
Company reiterates 2019 guidance of total net revenues between $160.0 and $175.0 million, including approximately $30.0 million of licensing revenues 
From GlobeNewswire News Releases
Novelion Therapeutics Observes World Lipodystrophy Day
Novelion Therapeutics Inc. (NASDAQ: NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases, in association with its subsidiary... 
From GlobeNewswire News Releases
The Daily Biotech Pulse: KaryoPharm's Selinexor Review Delayed, FDA Accepts Adamas Opioid Overdose Drug NDA
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags ARRY ACHV Biotech
From Benzinga
Novelion Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
Novelion Therapeutics Inc. (NASDAQ: NVLN), a biopharmaceutical company dedicated to developing and commercializing therapies for individuals living with rare diseases (“Novelion” or the “Company”),... 
From GlobeNewswire News Releases
Novelion Therapeutics Observes Rare Disease Day
Company Joins NORD, EURORDIS, CORD, The Global Genes Project and Others Worldwide in Supporting Awareness of Rare Diseases 
From GlobeNewswire News Releases
Paramount Developments Crucial for Advancing Clinical Trials Targeting Cancer Treatments
Financialnewsmedia.com News Commentary 
From PR Newswire
Paramount Developments Crucial for Advancing Clinical Trials Targeting Cancer Treatments
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
62 Biggest Movers From Yesterday
Gainers MacroGenics, Inc. (NASDAQ: MGNX) surged 130.42 percent to close at $25.60 on Wednesday after reporting positive results ... 
Tags General MCHP CEMI
From Benzinga
Mid-Afternoon Market Update: Container Store Drops On Earnings Miss; MacroGenics Shares Climb
Toward the end of trading Wednesday, the Dow traded down 0.01 percent to 25,408.42 while the NASDAQ declined 0.37 percent to 7,374.74. ... 
Tags PTI NVLN Markets
From Benzinga
48 Stocks Moving In Wednesday's Mid-Day Session
Gainers MacroGenics, Inc. (NASDAQ: MGNX) jumped 150.2 percent to $27.80 after reporting positive results from pivotal Phase 3 ... 
Tags TENB INVE SWKS
From Benzinga
Mid-Day Market Update: Snap Surges After Strong Q4 Results; Arlo Technologies Shares Slide
Midway through trading Wednesday, the Dow traded down 0.10 percent to 25,386.16 while the NASDAQ declined 0.33 percent to 7,377.76. The ... 
Tags CALX MGNX Commodities
From Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.